Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis

Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0

Abstract

Background Self-Monitoring of Blood Glucose (SMBG) is considered as a key factor in management of people with diabetes which is a growing and cost demanding health problem. The purpose of this study was to investigate the effect of comprehensive patient management using structured SMBG on metabolic control as well as its cost consequence analysis. Methods Sixty subjects were recruited in an observational study for a period of 6 months. They were provided with the ACCU-CHEK 360degrees View tool to fill in the values of the 7-point blood glucose profiles in three consecutive days during the study on a monthly basis. Changes in metabolic control were assessed by HbA1c and lipid profile measurement at the beginning and at the end of the study. In addition, cost consequence analysis was done considering different level of health care professionals with or without insurance coverage. The Average Cost Effectiveness Ratio (ACER) as well as Cost saving analysis were calculated and compared. Results The analysis showed significant reduction in HbA1c during the 6-month period in all subjects (P = 0.000). Furthermore, a positive effect was observed on lipid profile. The cost of endocrinologist's visit in private sector was estimated to be 265.76 USD while this figure was149.15 USD for general practitioner in public sector with insurance coverage. Total complications and mortality cost saving was 154.8 USD. The lowest ACER was calculated for intervention with general practitioner in public sector with insurance coverage.Conclusion Structured SMBG results in significant improvement of glycemic status. Moreover, it is more cost saving in public sector with insurance coverage. It seems that general practitioner visits with insurance coverage is the most affordable option for people with type 2 diabetes.

Authors and Affiliations

Mojtaba Malek, Rokhsareh Aghili, Mohammad E Khamseh, Shahin Yarahmadi, Amir Farshchi

Keywords

Related Articles

Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones

The currently available antifungal drugs suffer from toxicity, greatest potential drug interactions with other drugs, insufficient pharmacokinetics properties, and development of resistance. Thus, development of new anti...

Reporting of adverse drug reactions: An exploratory study among nurses in a teaching hospital, Ajman United Arab Emirates

Background and the purpose of the study Adverse drug reactions (ADRs) are important public health problem with significant morbidity, mortality and financial burden on the society. Nurses play important role in medicatio...

GC-MS analysis of insecticidal essential oil of flowering aerial parts of Saussurea nivea Turcz

Several species from Saussurea have been used in the traditional medicine, such as S. lappa, S. involucrate, and S. obvallata. There is no report on medicinal use of S. nivea. The aim of this research was to determine ch...

The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: One step forward in dosing

Backgrounds Magnesium has been known for its antioxidative and antiinflammatory properties in many studies. In this study two dosing regimens of magnesium were compared with a placebo control group in order to investigat...

Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design

Background and purpose of the study Glimepiride (GLM) was chosen as a model substrate in order to determine the kinetic parameters for in vitro metabolism via human liver micrososmes (HLM). We aimed to optimize the turno...

Download PDF file
  • EP ID EP135285
  • DOI -
  • Views 96
  • Downloads 0

How To Cite

Mojtaba Malek, Rokhsareh Aghili, Mohammad E Khamseh, Shahin Yarahmadi, Amir Farshchi (2012). Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis. DARU Journal of Pharmaceutical Sciences, 20(0), 1-13. https://europub.co.uk/articles/-A-135285